Biophagy is awarded a New Mexico Small Business Assistance (NMSBA) leverage grant with Sandia National Laboratories to lead a team of four companies (including Avisa Pharma, PureInfo Discovery, and Omphalos Biosciences) to investigate binding dynamics of several proprietary autophagy stimulants on cytoskeleton and lysosome movement. They will also study compound enhancement of antibiotic killing using M. bovis, in mouse macrophages. This is a surrogate assay for tuberculosis.By jordan|2022-03-22T20:38:46+00:00February 1, 2022|Categories: 2018-announcements|0 CommentsRead More
Biophagy announces the addition of Ian Henderson, PhD, as its head of medicinal chemistryBy jordan|2022-02-01T19:09:25+00:00February 1, 2022|Categories: 2017-announcements|0 CommentsRead More
Biophagy, working with Sandia National Laboratories, is awarded an individual company grant from NMSBA to study the relative potencies and binding sites of several autophagy stimulant combinations.By jordan|2022-03-22T20:39:10+00:00February 1, 2022|Categories: 2017-announcements|0 CommentsRead More
Biophagy, working with Sandia National Laboratories, is awarded an individual company grant from NMSBA to study the binding sites and autophagy stimulating activities of several UNM compounds under consideration for licensing.By jordan|2022-03-22T20:39:42+00:00February 1, 2022|Categories: 2016-announcements|0 CommentsRead More
Biophagy opens a second office in Mountainair, NMBy jordan|2022-02-01T19:08:54+00:00February 1, 2022|Categories: 2016-announcements|0 CommentsRead More
Albuquerque Business First awards Dr. Mary Ortner, Biophagy’s CEO, its Woman of Influence award in recognition of her contributions to business development in Albuquerque.By jordan|2022-03-22T20:40:02+00:00February 1, 2022|Categories: 2016-announcements|0 CommentsRead More